Clinical Trials · NCT07096908
Tirzepatide Use in People With Obesity and Type 1 Diabetes
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Dasman Diabetes Institute
- Enrollment
- 60
- Start date
- Jul 2025
- Locations
- 1 site, Kuwait
- Primary endpoint
- Bodyweight